INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 427m ago
HOUSE PTR27m ago
SEC 13F27m ago
ROBINHOOD CHAIN27m ago
Public company

ACTUACTUATE THERAPEUTICS, INC.

CIK 0001652935

EDGAR filingsOpen in network
Disclosed transactions31
Buys / sells2 / 0
Max Insider Score41
Connections15with evidence

ACTU · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
269.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    BIOS Fund III QP, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    BIOS Fund III NT, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    BIOS Fund I, LPDirector, 10% Owner · Oct 30, 2026
9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A
—
87.7K sh
Oct 28, 2026
Oct 30, 2026
traded Oct 28, 2026
+2d
SEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
682.9K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
195.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
368.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
48.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
82.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
36.1K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
82.5K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
133.1K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
824.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
126.2K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
65.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
87.7K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
682.9K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
195.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
368.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
48.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
36.1K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
269.3K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
82.5K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
133.1K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
824.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
126.2K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BI
BIOS Fund I, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
82.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

9
BF
BIOS Fund III, LPDirector, 10% Owner
ACTUACTUATE THERAPEUTICS, INC.
Grant or award
A—
65.0K sh
Oct 28, 2026Oct 30, 2026
traded Oct 28, 2026
+2dSEC FORM 4

Evidence

37
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Open-market purchase
BUY$50K
140.8K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC FORM 4

Evidence

41
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Open-market purchase
BUY—
70.4K sh
Oct 28, 2026Oct 29, 2026
traded Oct 28, 2026
+1dSEC FORM 4

Evidence

9
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Option exercise
M—
272.1K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC FORM 4

Evidence

21
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Option exercise
M—
272.1K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC FORM 4

Evidence

24
SM
Schmitt Daniel MDirector, President, CEO and Director
ACTUACTUATE THERAPEUTICS, INC.
Tax withholding
F$122K
120.5K sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Bios 2024 Co-Invest, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    BIOS Actuate Co-Invest I, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    BIOS Actuate Co-Invest II, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    BIOS Fund III, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    Bios Clinical Opportunity Fund, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    BIOS Fund I QP, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    BIOS Fund II NT, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    BIOS Fund II QP, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    BIOS Fund II, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    Bios Actuate Co-Invest III, LPDirector, 10% Owner · Oct 30, 2026
  • ← Insider ofevidence
    Schmitt Daniel MDirector, President, CEO and Director · Aug 14, 2026